"Supply shortages have been affecting various eye drops for several months for a variety of reasons. These shortages are now exacerbated by the difficulties encountered at Excelvision's French production site," the ANSM points out. in a statement.
“ These tensions mainly concern single-dose eye drops, in an already fragile international context for certain ophthalmic drugs.", explains the health authority. For some medications, alternatives or different presentations can cover part of the patients' needs, it says.
She recommends that healthcare professionals " limit prescriptions and dispensations to the quantities strictly necessary » and »avoid building up precautionary stocks"Eye drops are medications presented in the form of eye drops or gel that are applied to the eye.
Read also Up to €1.7 billion worth of unused medication each year
Drug availability, a recurring problem for several years
They are indicated as part of an examination, such as to dilate the pupil, or for local treatment of the eye with antibiotic, anesthetic, anti-allergic, anti-inflammatory eye drops, etc.
Read also Medicines: have there been stock shortages in 2024?
Drug availability problems, which have multiple causes, have been recurring for several years and affect many countries. These problems can stem from difficulties encountered during the manufacturing of raw materials or finished products, quality defects, or insufficient production capacity.
English 
French